Lin Wang Selected Research

Lin Wang Research Topics

Disease

720	Neoplasms (Cancer) 07/2024 - 11/2002
193	Infections 05/2024 - 12/2002
183	Inflammation (Inflammations) 05/2024 - 09/2002
131	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2008
79	Fibrosis (Cirrhosis) 04/2024 - 12/2002
76	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 02/2003
75	Breast Neoplasms (Breast Cancer) 02/2024 - 12/2002
70	Carcinogenesis 03/2024 - 05/2002
63	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2010
62	Wounds and Injuries (Trauma) 05/2024 - 07/2003
62	COVID-19 04/2024 - 01/2020
57	Lung Neoplasms (Lung Cancer) 05/2024 - 08/2008
56	Hypoxia (Hypoxemia) 12/2024 - 06/2007
53	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 09/2007
52	Carcinoma (Carcinomatosis) 11/2023 - 11/2002
51	Squamous Cell Carcinoma of Head and Neck 12/2023 - 04/2005
50	Pain (Aches) 03/2024 - 11/2007
50	Stomach Neoplasms (Stomach Cancer) 06/2023 - 12/2004
49	Nasopharyngeal Carcinoma 02/2024 - 01/2013
47	Stroke (Strokes) 05/2024 - 01/2013
47	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 10/2006
41	Hypertension (High Blood Pressure) 12/2023 - 02/2004
40	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2004
38	Glioma (Gliomas) 02/2024 - 04/2013
36	Reperfusion Injury 02/2024 - 01/2004
35	Body Weight (Weight, Body) 01/2024 - 11/2006
35	Ischemia 08/2023 - 01/2004
34	Adenocarcinoma 02/2023 - 04/2008
33	Rectal Neoplasms (Rectal Cancer) 02/2024 - 05/2010
33	Adenocarcinoma of Lung 01/2023 - 04/2010
32	Disease Progression 04/2024 - 03/2011
31	Myocardial Infarction 10/2023 - 11/2004
30	Heart Failure 05/2024 - 12/2003
29	Ischemic Stroke 05/2024 - 01/2014
29	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 12/2009
29	Atherosclerosis 12/2023 - 01/2005
27	Bacterial Infections (Bacterial Infection) 03/2024 - 04/2009
27	Ovarian Neoplasms (Ovarian Cancer) 09/2023 - 12/2002
26	Type 2 Diabetes Mellitus (MODY) 12/2023 - 03/2005
26	Colonic Neoplasms (Colon Cancer) 01/2023 - 04/2004
26	Arthritis (Polyarthritis) 01/2023 - 07/2011
25	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 11/2002
25	Lymphatic Metastasis 01/2023 - 04/2008
24	Diabetes Mellitus 04/2024 - 01/2010
24	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 09/2014
24	Brain Injuries (Brain Injury) 01/2024 - 11/2007
23	Liver Neoplasms (Liver Cancer) 05/2024 - 02/2002
23	Pneumonia (Pneumonitis) 04/2024 - 10/2009
23	Neuroinflammatory Diseases 03/2024 - 04/2016
22	Insulin Resistance 04/2024 - 07/2008
21	Tuberculosis (Tuberculoses) 05/2024 - 11/2006
21	Periodontitis 05/2024 - 02/2013
21	Asthma (Bronchial Asthma) 05/2024 - 01/2003
21	Sepsis (Septicemia) 04/2024 - 03/2010
21	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2013
21	Obesity 04/2023 - 04/2013

Drug/Important Bio-Agent (IBA)

279	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2002
175	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2004
102	CytokinesIBA 03/2024 - 09/2002
101	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2009
84	Messenger RNA (mRNA)IBA 03/2024 - 01/2004
57	Therapeutic UsesIBA 05/2024 - 12/2004
57	RNA (Ribonucleic Acid)IBA 04/2024 - 02/2012
57	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 09/2002
45	EnzymesIBA 04/2024 - 09/2005
44	VaccinesIBA 04/2024 - 07/2005
44	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 03/2011
44	Phosphotransferases (Kinase)IBA 01/2023 - 07/2005
42	Long Noncoding RNAIBA 12/2023 - 01/2015
42	Small Interfering RNA (siRNA)IBA 01/2023 - 06/2006
41	LipidsIBA 12/2024 - 01/2006
38	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 08/2008
37	CollagenIBA 11/2023 - 12/2003
36	Transcription Factors (Transcription Factor)IBA 01/2024 - 04/2005
35	Peptides (Polypeptides)IBA 03/2024 - 02/2004
34	AntigensIBA 04/2024 - 09/2004
34	ErbB Receptors (EGF Receptor)IBA 02/2024 - 12/2010
32	Indicators and Reagents (Reagents)IBA 01/2024 - 03/2005
31	AntioxidantsIBA 04/2024 - 09/2013
31	Antiviral Agents (Antivirals)IBA 04/2024 - 07/2005
30	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 05/2004
29	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 09/2002
28	Interleukin-6 (Interleukin 6)IBA 03/2024 - 03/2005
26	HydrogelsIBA 04/2024 - 08/2013
25	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 08/2009
25	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2023 - 11/2007
24	AntibodiesIBA 01/2024 - 05/2006
24	LigandsIBA 01/2023 - 06/2006
22	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2004
21	Tyrosine Kinase InhibitorsIBA 02/2024 - 05/2011
21	Estrogens (Estrogen)FDA Link 01/2024 - 08/2010
21	Carrier Proteins (Binding Protein)IBA 10/2023 - 08/2005

Therapy/Procedure

312	Therapeutics 05/2024 - 09/2002
141	Drug Therapy (Chemotherapy) 04/2024 - 07/2004
69	Radiotherapy 04/2024 - 01/2008
45	Immunotherapy 05/2024 - 01/2008
42	Neoadjuvant Therapy 02/2024 - 04/2011
29	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2005
25	Chemoradiotherapy 02/2024 - 12/2010
21	Aftercare (After-Treatment) 12/2023 - 07/2003